Phase I study of the anthrapyrazole biantrazole: clinical results and pharmacology (Q70168068)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040034%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Phase I study of the anthrapyrazole biantrazole: clinical results and pharmacology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040034%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

S G Allan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040034%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

J Cummings

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040034%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

S Evans

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040034%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

M Nicolson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040034%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

M E Stewart

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040034%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

J Cassidy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040034%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

M Soukop

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040034%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

S B Kaye

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040034%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

J F Smyth

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040034%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040034%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

9 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040034%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040034%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040034%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

55-58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040034%20AND%20SRC:MED&resulttype=core&format=json

5-[(Aminoalkyl)amino]-substituted anthra[1,9-cd]pyrazol-6(2H)-ones as novel anticancer agents. Synthesis and biological evaluation

9 October 2019

cites work

1 reference

12 December 2020

In vitro DNA strand scission and inhibition of nucleic acid synthesis in L1210 leukemia cells by a new class of DNA complexers, the anthra[1,9-cd]pyrazol-6(2H)-ones (anthrapyrazoles).

1 reference

12 December 2020

Risk factors for doxorubicin-induced congestive heart failure

1 reference

12 December 2020

Experience with the use of adriamycin in combination with other anticancer agents using a weekly schedule, with particular reference to lack of cardiac toxicity

1 reference

12 December 2020

Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors.

1 reference

12 December 2020

The anthracycline antineoplastic drugs

1 reference

12 December 2020

Pharmacology of adriamycin: the message to the clinician

1 reference

12 December 2020

Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response

1 reference

12 December 2020

The effect of the anthrapyrazole antitumour agent CI941 on rat liver microsome and cytochrome P-450 reductase mediated free radical processes. Inhibition of doxorubicin activation in vitro

1 reference

12 December 2020

Design, biochemical pharmacology, electrochemistry and tumour biology of anti-tumour anthrapyrazoles.

1 reference

12 December 2020

Mitoxantrone: a new anticancer drug with significant clinical activity

1 reference

12 December 2020

Determination of the anthrapyrazole anticancer drug CI-941 in plasma and urine by solid-phase extraction and high-performance liquid chromatography

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00684957

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2040034%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference